Waystar Holding Corp(WAY) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 30 at 4:00 PM ET (Korea 10/31 05:00)
Full metrics table
| Index | RUT | P/E | 39.87 | EPS (ttm) | 0.7 | Insider Own | 30.63% | Shs Outstand | 191.9M | Perf Week | -2.95% |
| Market Cap | 5.37B | Forward P/E | 14.89 | EPS next Y | 12.61% | Insider Trans | -0.54% | Shs Float | 133.0M | Perf Month | 10.45% |
| Enterprise Value | 6.63B | PEG | 0.97 | EPS next Q | 0.41 | Inst Own | 88.25% | Short Float | 11.66% | Perf Quarter | 23.57% |
| Income | 0.13B | P/S | 4.45 | EPS this Y | 17.57% | Inst Trans | 4.75% | Short Ratio | 6.6 | Perf Half Y | 33.65% |
| Sales | 1.21B | P/B | 1.35 | EPS next 5Y | 15.42% | ROA | 2.56% | Short Interest | 15.51M | Perf YTD | -14.5% |
| Book/sh | 20.77 | P/C | 23.93 | EPS past 3/5Y | - | ROE | 3.77% | 52W High | -28.94% ($39.40) | Perf Year | -24.45% |
| Cash/sh | 1.17 | P/FCF | 21.8 | Sales past 3/5Y | 15.97% 17.41% | ROIC | 2.47% | 52W Low | 62.22% ($17.26) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | 14.33 | EPS Y/Y TTM | 44.44% | Gross Margin | 56.11% | Volatility(W/M) | 3.22% 4.06% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 5.5 | Sales Y/Y TTM | 19.23% | Oper. Margin | 25.36% | ATR (14) | 1.03 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.85 | EPS Q/Q | 18.57% | Profit Margin | 11.18% | RSI (14) | 55.32 | Recom | 1.2 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.85 | Sales Q/Q | 18.11% | SMA20 | 1.35% ($27.63) | Beta | 0.16 | Target Price | $34.09 |
| Payout | - | Debt/Eq | 0.37 | Earnings | 2026/11/2 | SMA50 | 7.01% ($26.17) | Rel Volume | 0.54 | Prev Close | $28.21 |
| Employees | 1700 | LT Debt/Eq | 0.37 | EPS/Sales Surpr. | 8.04% 1.1% | SMA200 | 17.21% ($23.89) | Avg Volume(3M) | 2.35M | Price | $28 |
| IPO | 2024/6/7 | Option/Short | Yes/Yes | Trades | 12423 | Volume | 1,263,630 | Change | -0.74% |
💳 A healthcare technology company that provides medical billing and revenue cycle management software. It automates revenue cycle management for healthcare providers—including billing, insurance claims, and patient payments—through cloud-based software, with a key strength in AI-powered claims processing. The company operates in the medical billing software sector.
Over the past 1 year, roughly in the middle
29% below its 1-year high.
Traded less than usual. That is 54% of its average volume.
Next earnings report: November 2
3 days to go.
WAY earns at a steady pace
Of every $100 in sales, $25.36 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +17.6% this year.
Tap to view numbers
The price is about the industry average
For a company expected to earn $100 next year, you would pay $1,489. Peers typically go for $2,159. Compared with its own 2-year average, it is 22% cheaper now.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership is about average
Institutions hold 88.3%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
HEAL Global X HealthTech ETF 0.03% 
BCSM Baron SMID Cap ETF 0.01% 
PSCH Invesco S&P SmallCap Health Care ETF 0.01% 
EKG First Trust Nasdaq Lux Digital Health Solutions ETF 0.01% 
IPO Renaissance IPO ETF 0.01% Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.
ENOR iShares MSCI Norway ETF 344M 
NORW Global X MSCI Norway ETF 95M It ranks #7 of 41 in the industry
Based on market cap of $5B.
HNGE#4 Hinge Health Inc $9B PER 88.0 
HQY#5 Healthequity Inc $8B PER 37.0 
DOCS#6 Doximity Inc $6B PER 38.9 WAY#7 Waystar Holding Corp $5B PER 39.9 
HTFL#8 Heartflow Inc $5B PER - 
FAQ
What kind of company is WAY?
WAY belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of WAY?
The market cap of WAY is approximately $5.4B, ranking 1,317 within its sector.
What is the P/E ratio of WAY?
WAY has a P/E ratio of approximately 39.9x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for WAY?
WAY has recorded a 52-week high of $39.40 and a low of $17.26.
